Where does Ariosa Diagnostics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Ariosa Diagnostics, Inc. ranks #11,921 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Ariosa Diagnostics, Inc. hold?

Ariosa Diagnostics, Inc. holds 25 US utility patents granted between 2015 and 2025, spanning 3 technology areas.

What is Ariosa Diagnostics, Inc.'s Innovation Score?

Ariosa Diagnostics, Inc. has an Innovation Score of 32.1 out of 100 (40th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Ariosa Diagnostics, Inc.'s patent grant rate increasing or decreasing?

Ariosa Diagnostics, Inc.'s recent grant velocity is +0% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Ariosa Diagnostics, Inc.'s patents?

Ariosa Diagnostics, Inc.'s patents average 22.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Ariosa Diagnostics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Ariosa Diagnostics, Inc.

Q: What technology areas does Ariosa Diagnostics, Inc. focus on?

Ariosa Diagnostics, Inc.'s top technology area is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes) with 20 patents, ranking #236 of 2,502 assignees active in that subclass. Grants appear in 3 CPC subclasses total.

USPTO PatentsView assignee record - 25 granted patents across 3 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Ariosa ranks #11,921 of 49,997 tracked US assignees by granted-patent volume, with 25 patents across 3 technology areas.

#11,921
of 49,997 US assignees by volume: 40th percentile
by Innovation Score (32.1/100): 22.0
avg claims per patent: +0%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R11921 · US Corporation #11,921 · 25 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-FLAT · BOOK-FULL

GRANTS-SMALL 25 grants
UPPER-Q #11,921/49,997
PHOTO-FINISH Alpine of Silicon…
CPC-NARROW C12Q · 3 areas
INNOV-THIN 32.1/100
CLAIMS-DENSE 22.0 claims/avg
TYPE-USCORP US Corporation
VEL-FLAT +0% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Alpine Electronics of Silicon Valley, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Ariosa’s 32.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.3 pts (35%) Velocity 1.5 pts (5%) Breadth 6.1 pts (19%) Claim depth 13.2 pts (41%)

Qualcomm Incorporated · highest

85
Ariosa Diagnostics · this assignee

32
Encore Packaging · near

32
Kleverness Incorpora… · near

32
Rebound Therapeutics · near

32
Athalonz · near

32
3D Lighting… · lowest

7

What this shows Ariosa's Innovation Score is 32.1/100 (40th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Ariosa?

Each dot is one of Ariosa’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Ariosa’s own 22.0 claims/patent is ABOVE the 12.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Ariosa vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Ariosa's grants concentrate

Ariosa Diagnostics, Inc. is a focused PatentsView assignee: 3 CPC subclasses with 80% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2018 (5 grants) versus a trough of 1 in 2015. By volume, Ariosa sits between Alpine Electronics of Silicon Valley, Inc. and Aurobindo Pharma Ltd.

Ariosa's three-year grant acceleration

Ariosa Diagnostics, Inc. shows 3 grants in 2022–2024 against only 13 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Alpine of Silicon…

25
Altek

25
Anellotech

25
Anhui Inno-sign I…

25
Arla Foods Amba

25
Aspen Surgical Pr…

25
Attopsemi Technol…

25
Aurobindo Pharma

25
Ariosa Diagnostics ◀

25

What this shows Ariosa holds 25 patents at rank #11,926, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Ariosa

By rank, the assignees closest to #11,926 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in Ariosa's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Ariosa, neither rank-band nor same-CPC leaders (those blocks stay above). In C12Q (Measuring OR Testing Processes Involving Enzymes), Ariosa ranks #236 of 2,502 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (32 here).

Rebound Therapeutics Corporation 32 Encore Packaging LLC 32 Kleverness Incorporated 32 Athalonz, LLC 32

Ariosa's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

32 40th percentile higher than 40% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Ariosa Diagnostics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	4.0%
2017	2	8.0%
2018	5	20.0%
2019	4	16.0%
2020	4	16.0%
2021	5	20.0%
2022	3	12.0%
2025partial year	1	4.0%

Which technologies does Ariosa Diagnostics, Inc. patent most?

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 20

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 12

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 2

Top 3 of 3 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Ariosa Diagnostics, Inc.'s patent record in context - here's where to go next.

Ariosa Diagnostics, Inc.'s lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 80% of its portfolio - see every assignee active in that class. Explore C12Q
Ranked #11,921 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Ariosa Diagnostics, Inc. against Alpine Electronics of Silicon Valley, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 32.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.